3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Boehringer Ingelheim Investigational Site, Annaka, Gunma

Boehringer Ingelheim Investigational Site, Asahi,Chiba

Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

Boehringer Ingelheim Investigational Site, Ichinomiya, Aichi

Boehringer Ingelheim Investigational Site, Iida,Nagano

Boehringer Ingelheim Investigational Site, Inzai, Chiba

Boehringer Ingelheim Investigational Site, Isesaki, Gunma

Boehringer Ingelheim Investigational Site, Kako-gun, Hyogo

Boehringer Ingelheim Investigational Site, Kasuya-gun,Fukuoka

Boehringer Ingelheim Investigational Site, Katsushika-ku,Tokyo

Boehringer Ingelheim Investigational Site, Kobe, Hyogo

Boehringer Ingelheim Investigational Site, Koshigaya, Saitama

Boehringer Ingelheim Investigational Site, Mono-gun, Miyagi

Boehringer Ingelheim Investigational Site, Osaka, Osaka

Boehringer Ingelheim Investigational Site, Osaka, Osaka

Boehringer Ingelheim Investigational Site, Sendai, Miyagi

Boehringer Ingelheim Investigational Site, Setagun, Gunma

Boehringer Ingelheim Investigational Site, Shinjyuku, Tokyo

Boehringer Ingelheim Investigational Site, Shiroishi, Miyagi

Boehringer Ingelheim Investigational Site, Shiroishi, Miyagi

Boehringer Ingelheim Investigational Site, Suita, Osaka

Boehringer Ingelheim Investigational Site, Takasaki, Gunma

Boehringer Ingelheim Investigational Site, Taya-gun, Gunma